Navigation Links
In US first, Johns Hopkins surgeons implant brain 'pacemaker' for Alzheimer's disease
Date:12/5/2012

Researchers at Johns Hopkins Medicine in November surgically implanted a pacemaker-like device into the brain of a patient in the early stages of Alzheimer's disease, the first such operation in the United States. The device, which provides deep brain stimulation and has been used in thousands of people with Parkinson's disease, is seen as a possible means of boosting memory and reversing cognitive decline.

The surgery is part of a federally funded, multicenter clinical trial marking a new direction in clinical research designed to slow or halt the ravages of the disease, which slowly robs its mostly elderly victims of a lifetime of memories and the ability to perform the simplest of daily tasks, researchers at Johns Hopkins say. Instead of focusing on drug treatments, many of which have failed in recent clinical trials, the research focuses on the use of the low-voltage electrical charges delivered directly to the brain. There is no cure for Alzheimer's disease.

As part of a preliminary safety study in 2010, the devices were implanted in six Alzheimer's disease patients in Canada. Researchers found that patients with mild forms of the disorder showed sustained increases in glucose metabolism, an indicator of neuronal activity, over a 13-month period. Most Alzheimer's disease patients show decreases in glucose metabolism over the same period.

The first U.S. patient in the new trial underwent surgery at The Johns Hopkins Hospital, and a second patient is scheduled for the same procedure in December. The surgeries at Johns Hopkins are being performed by neurosurgeon William S. Anderson, M.D.

"Recent failures in Alzheimer's disease trials using drugs such as those designed to reduce the buildup of beta amyloid plaques in the brain have sharpened the need for alternative strategies," says Paul B. Rosenberg, M.D., an associate professor of psychiatry and behavioral sciences at the Johns Hopkins University School of Medicine, and
'/>"/>

Contact: Stephanie Desmon
sdesmon1@jhmi.edu
410-955-8665
Johns Hopkins Medicine
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. First, do no harm: Study finds danger in standard treatment for a serious lung disease
2. First, Second Kidney Transplants Have Similar Success: Study
3. The US Drug Watchdog Now Urges Any Woman Who Used The Birth Control Pills Yaz Or Yasmin And Then Had A Heart Attack Or Stroke To Call The Johnson Law Group----ASAP
4. The US Drug Watchdog Now Urges Women Who Suffered A Heart Attack Or Stroke After Using Yaz Yasmin Birth Control Pills To Contact The Johnson Law Group Immediately
5. Johns Hopkins scientists pair blood test and gene sequencing to detect cancer
6. Results from study of Mead Johnsons Enfamil® Human Milk Fortifier Acidified Liquid published in Pediatrics
7. Johns Hopkins Armstrong Institute receives $8.9 million patient safety grant
8. Johns Hopkins team finds ICU misdiagnoses may account for as many annual deaths as breast cancer
9. Johns Hopkins researchers return blood cells to stem cell state
10. Johnson & Johnson Violated FDA Order to Halt Sales of Transvaginal Mesh
11. Johns Hopkins African bioethics program receives 5-year continuation grant from NIH
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... 2015 Fast on the heels of ... Amounts, and Allison Folmar, JD, join over 150 speakers ... , On Sunday, May 24, the conference presents "I ... Are you interested in Ryan Hinds' recovery story? The ... war against autism was written by Marcia Hinds, ...
(Date:5/4/2015)... Sara Soulati, CEO of Global ... in Los Angeles associated with the field of Enhanced ... The Sara Soulati Health For Life Program (SSHFLP). , ... lifestyle modification and disease prevention program. A provisional ... S. Patents and Trademarks Office and is now under ...
(Date:5/3/2015)... May 03, 2015 Leading international program ... it will be awarding the 2015 Harris Wofford Global ... Selemawit Ghebrendrias, are the deserving recipients of the award ... service, Harris Llewellyn Wofford. The two recipients were chosen ... for global health. , CFHI is one of ...
(Date:5/3/2015)... CA (PRWEB) May 03, 2015 NuevaCare ... MnemeTherapy® at two upcoming area seminars. The first event ... PSA Annual Regional Stroke Conference to be held at ... offered on Wednesday, May 13 during the Dementia Conference ... , “These seminars offer an excellent opportunity to ...
(Date:5/2/2015)... NV (PRWEB) May 02, 2015 Ticket Down ... tickets for the long awaited event today, Saturday, May ... Diehard boxing fans will be able to secure tickets ... , The fight that boxing fans have wanted for more ... months ago. Floyd “Money” Mayweather will step inside the ring ...
Breaking Medicine News(10 mins):Health News:Perhaps the most important information families touched by autism will ever hear is available this month at international conference in Chicago 2Health News:Perhaps the most important information families touched by autism will ever hear is available this month at international conference in Chicago 3Health News:Perhaps the most important information families touched by autism will ever hear is available this month at international conference in Chicago 4Health News:CEO Sara Soulati Announces Patent-Pending Designation For The Sara Soulati Health For Life Program 2Health News:SF-based Global Health Non-Profit Awards Harris Wofford Global Service Fellowship 2Health News:SF-based Global Health Non-Profit Awards Harris Wofford Global Service Fellowship 3Health News:NuevaCare Introduces MnemeTherapy® Approach to Care for Elderly Patients with Alzheimer’s, Stroke and Other Types of Neurodegenerative Conditions 2Health News:Cheap Floyd Mayweather vs. Manny Pacquiao Tickets: Ticket Down Has Last Minute Tickets for Mayweather vs. Pacquiao at the MGM Grand Garden Arena in Las Vegas 2Health News:Cheap Floyd Mayweather vs. Manny Pacquiao Tickets: Ticket Down Has Last Minute Tickets for Mayweather vs. Pacquiao at the MGM Grand Garden Arena in Las Vegas 3
... suggests that the presence of tumor cells in the circulating ... and neck may predict disease recurrence and reduced survival. An ... a worse outcome. Those are the early ... of CTCs by a team of researchers at The Ohio ...
... , TUESDAY, Dec. 21 (HealthDay News) -- Certain ... fat, according to an animal study that might one day ... tests on mice, a team at the Joslin Diabetes Center ... caused progenitor cells in subcutaneous (just beneath the skin) white ...
... with locally advanced head and neck cancers who successfully ... so without losing the ability to speak clearly and ... Institute. "This is good news," said Joseph K. ... Duke and the corresponding author of the study. "I ...
... robotic surgery for upper airway and digestive track malignant ... techniques based on patient function and survival, according to ... neck squamous cell carcinomas account for about 4 percent ... year. Currently the standard minimally invasive surgery for these ...
... HealthDay Reporter , MONDAY, Dec. 20 (HealthDay News) ... for strict heart rate control in patients with atrial ... strokes. More lenient management of the condition is ... guidelines from the American College of Cardiology and the ...
... , MONDAY, Dec. 20 (HealthDay News) -- ... swallow after undergoing combined chemotherapy and radiation treatment, but ... have found. The new study included patients who ... treated with chemoradiotherapy for advanced head and neck cancer. ...
Cached Medicine News:Health News:Tumor cells in blood may signal worse prognosis in head and neck cancer patients 2Health News:Factors linked to speech/swallowing problems after treatment for head and neck cancers 2Health News:Robotic surgery for head and neck cancer shows promise 2Health News:Guidelines Eased for Patients With Irregular Heartbeats 2Health News:Guidelines Eased for Patients With Irregular Heartbeats 3Health News:Speech, Swallowing Usually OK After Head & Neck Cancer Therapy 2
(Date:5/1/2015)... 2015  Legendary actor and director Danny Glover ... campaign designed to educate and encourage patients with neurologic ... Affect (PBA) and to speak with their physician. The ... the ability to cry and laugh on cue and ... by people living with PBA episodes. While ...
(Date:5/1/2015)... 2015  Misonix, Inc. (NASDAQ: MSON ), ... and markets innovative therapeutic ultrasonic products for spine ... laparoscopic surgery and other surgical applications, announced today ... third quarter fiscal year 2015 on Thursday, May ... call that same day, Thursday, May 7, 2015, ...
(Date:4/30/2015)... April 30, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. ... with a focus on Omega-3 therapies for cardiovascular ... highlights and financial results for the fiscal year ... herein are in Canadian dollars unless otherwise stated. ... significant, with the right strategic partners and additional ...
Breaking Medicine Technology:Danny Glover Joins PBA Facts Campaign, to Educate and Build Awareness of Pseudobulbar Affect (PBA), a Little Known but Widespread Neurologic Condition 2Danny Glover Joins PBA Facts Campaign, to Educate and Build Awareness of Pseudobulbar Affect (PBA), a Little Known but Widespread Neurologic Condition 3Misonix, Inc. To Report Third Quarter Fiscal Year 2015 Financial Results On Thursday, May 7, 2015 2Pivotal Therapeutics Announces 2014 Financial Results 2Pivotal Therapeutics Announces 2014 Financial Results 3Pivotal Therapeutics Announces 2014 Financial Results 4Pivotal Therapeutics Announces 2014 Financial Results 5Pivotal Therapeutics Announces 2014 Financial Results 6
... HealthWarehouse.com, Inc. (OTC Bulletin Board: HEWA), a ... consummated two separate transactions to acquire all the online ... medications, diabetics supplies, and medical equipment, and merge with ... "The combination will bring together two companies committed ...
... and INGELHEIM, Germany, Feb. 15, 2011 Pfenex ... the Pfenex Expression Technology™ platform and Boehringer Ingelheim ... leader in biopharmaceutical contract development and manufacture, announced ... agreement. It provides Boehringer Ingelheim with non-exclusive access ...
Cached Medicine Technology:HealthWarehouse.com Acquires Online Division of Hocks Pharmacy 2Pfenex Inc. and Boehringer Ingelheim Announce Non-Exclusive Strategic Agreement for the Use of Pfenex Expression Technology™ 2Pfenex Inc. and Boehringer Ingelheim Announce Non-Exclusive Strategic Agreement for the Use of Pfenex Expression Technology™ 3